文献速递心外重症与机械循环支持

血管闭合装置与开放拔管在股动静脉ECMO中的比较

Vascular Closure Device vs Open Decannulation for Femoral Venoarterial Extracorporeal Membrane Oxygenation.
PubMed 文献 · Ann Thorac Surg · 2024-12-24

该单中心回顾性研究比较了MANTA血管闭合装置与开放拔管在股动静脉ECMO患者中的效果。结果显示MANTA组下肢并发症相对减少46%(26.1% vs 39.6%;OR 0.54;95%CI 0.28-1.00),且允许安全床旁拔管;远端灌注部位经皮闭合与手动压迫的SFA并发症无显著差异。

要点

  • MANTA拔管较开放拔管下肢并发症相对减少46%,支持床旁安全拔管。
  • SFA经皮闭合与手动压迫的并发症无显著差异(OR 0.71;95%CI 0.29-1.76)。

核心结论

  • MANTA拔管较开放拔管显著降低股动静脉ECMO患者的下肢并发症,并允许安全床旁拔管。
  • 经皮SFA闭合与手动压迫的结局等效。

研究设计与样本

  • 单中心回顾性研究,纳入2018年1月至2023年1月股动静脉ECMO拔管患者。
  • MANTA组94例(30例床旁),开放拔管组160例。
  • 排除非经皮置管或未使用MANTA的经皮拔管患者。

主要发现

  • 两组中位ECMO支持时间均为6天。
  • MANTA组4例修正为早期术者经验的技术失败。
  • 多变量模型中MANTA拔管下肢并发症相对减少46%(26.1% vs 39.6%;OR 0.54;95%CI 0.28-1.00)。
  • SFA手动压迫与经皮闭合的SFA并发症无显著差异(14.4% vs 10.7%;OR 0.71;95%CI 0.29-1.76)。

临床怎么用

  • 股动静脉ECMO拔管可考虑使用MANTA装置以降低下肢并发症并实现床旁拔管。
  • 远端灌注部位闭合可选择经皮闭合或手动压迫,两者SFA并发症等效。

局限性

  • 回顾性单中心设计,可能存在选择偏倚。
  • MANTA组早期术者经验导致部分技术失败。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Traditional decannulation of femoral venoarterial (VA) extracorporeal membrane oxygenation (ECMO) involves femoral cutdown. Percutaneous methods have been developed, but data supporting their use are limited. This study sought to compare the MANTA (Teleflex) vascular closure device with open decannulation. METHODS: The study investigators retrospectively reviewed patients decannulated from femoral VA ECMO from January 2018 to January 2023 at our institution (University of Maryland Medical Center, Baltimore, MD). Patients were excluded if cannulation was not percutaneous or if percutaneous decannulation was performed without MANTA use. The primary outcome was lower extremity complications. Closure of the distal perfusion site was compared between superficial femoral artery (SFA) manual pressure and percutaneous closure with MYNX (Cordis) or Angioseal (Terumo Medical Corporation). RESULTS: A total of 160 patients underwent open decannulation, and 94 patients (30 at bedside) underwent MANTA decannulation. Both groups had 6-day median ECMO support duration. The intraoperative revision rate between MANTA and open decannulation was similar (9 [9.6%] vs 26 [16.4%]; P = .13). Four revisions for MANTA were technical failures in early surgeon experience. In a multivariable model, there was a 46% relative reduction in lower extremity complications with MANTA decannulation compared with open decannulation (26.1% vs 39.6%; odds ratio, 0.54; 95% CI, 0.28-1.00). There was no significant difference in SFA complications between manual pressure and percutaneous closure (14.4% vs 10.7%; odds ratio, 0.71; 95% CI, 0.29-1.76). CONCLUSIONS: There is a significant reduction in lower extremity complications with MANTA decannulation compared with open decannulation from femoral VA ECMO, thus allowing for safe bedside decannulation. Percutaneous SFA closure has outcomes equivalent to those of manual pressure.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Shah A, Robinson J, Leibowitz J, et al. Vascular Closure Device vs Open Decannulation for Femoral Venoarterial Extracorporeal Membrane Oxygenation. Ann Thorac Surg. 2024. PMID: 39725253. doi:10.1016/j.athoracsur.2024.12.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。